Patent · US Active

Animal model for type 2 diabetes and obesity

US10299467B2 · kind B2 · utility

0Cited by

0References

4Claims

0Family size

Assignee

UNIVERSITAETSKLINIKUM FREIBURG · DE

Inventors

Roland Schüle · Weisweil, DE
Delphine Duteil · Illkirch-Graffenstaden, FR
Eric Metzger · Neuf-Brisach, FR
Thomas Günther · Heidelberg, DE

Key dates

Filing date	Oct 31, 2013
Grant date	May 28, 2019
Priority date	—
Expiry date	May 21, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2310/14
WIPO fieldBiotechnology
WIPO sectorChemistry

Abstract

The present invention relates to the use of a genetically modified non-human animal as an animal model for obesity or obesity-related disorders, wherein the amount of Lysine-specific Demethylase 1 (LSD1) in at least one tissue or at least one cell type of said animal is reduced.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.